MeSH Browser

MeSH Supplementary: HR-2 protocol
Unique ID: C098984
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C098984
Registry Numbers: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Dexamethasone; Ifosfamide; Methotrexate; Prednisolone; Thioguanine; Vindesine
Frequency: 1
Note: a chemotherapy protocol consisting of the above compounds; used in the treatment of high-risk acute lymphoblastic leukemia (HR-ALL)
Source: Blood 1996 Apr 15;87(8):3143-50
Date of Entry: 1996/05/16
Revision Date: 2000/11/30

HR-2 protocol MeSH Supplementary Concept Data 2025